Paclitaxel plus bevacizumab for metastatic breast cancer.
Rossi
Antonio
A
Torri
Valter
V
Gridelli
Cesare
C
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D015982:Bias; D001943:Breast Neoplasms / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012107:Research Design
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel